New Clinical Study ABOUT HFDS
The Research Institute of Ophthalmology, Egypt and Kasr Ainy School of Medicine, Cairo University have published a study on the HFDS procedure. The study shows that HFDS achieves a significant intraocular pressure (IOP) reduction and it is a safe and promising minimally invasive procedure for patients with chronic open-angle glaucoma.
In the surgical treatment of glaucoma, Oertli's surgical platforms provide significant added value in microinvasive glaucoma surgery (MIGS). The High Frequency Deep Sclerotomy (HFDS) establishes a direct access to the Schlemm's canal in front of the anterior chamber and further into the sclera, bypassing the drainage resistance of the trabecular meshwork. This ensures a minimal complication rate and good long-term results despite the short duration of the procedure.